Jeff Williamson has joined the RNA Advisors growing healthcare practice as Director. Mr. Williamson will focus on providing a greater breadth and depth of strategic advisory services to our healthcare, medical device, and life sciences clients.
Mr. Williamson brings over 15 years of strategy consulting experience in healthcare and life sciences, with particular expertise in provider & payer strategy, population health management, biopharma commercial forecasting, and epidemiology. He has led project teams to assist healthcare companies in addressing a number of key strategic issues, including market sizing & assessment, operational improvement, new product launches, competitive analysis, and due diligence support for both buy-side and sell-side clients. He has deep experience in forecasting, analytics, and strategic planning across a broad range of therapeutic areas.
Prior to joining RNA, Mr. Williamson was an Engagement Manager in L.E.K. Consulting’s Healthcare practice, and served as the Vice President of Market Access for an oncology startup that provides genetic sequencing services and therapy recommendations for patients with cancer. Mr. Williamson earned MBA and MPH degrees from the University of California, Berkeley.
Sam Renwick, founding partner of RNA, said, “Increasingly, our clients are requesting help to devise strategies to capitalize on market opportunities. Adding Jeff to our strategic advisory practice will allow us to increase the depth and breadth of services we can offer to client company leadership teams.”
Jeff Williamson commented, “RNA Advisors has carried over the same high standard it has set in financial & valuation services to strategic advisory projects that help clients transform market possibilities into commercial realities. I look forward to further developing RNA’s strategic consulting practice to help clients realize the full potential of their opportunities.”
About RNA Capital Advisors
RNA provides a unique blend of evidence-based strategy consulting and advanced financial modeling and valuation analytics to help our healthcare, life science and technology clients optimize outcomes for important issues. Better decisions and opinions come from credible, consistent, and evidenced-based perspectives supported by the analytic tools that help identify potential and mitigate risk. We help our clients through buy-side and sell-side support, internal strategic decision support and independent opinion services.
RNA Capital Advisors